Angeles Investment Advisors LLC Has $224,000 Stock Position in McKesson Co. (NYSE:MCK)

Angeles Investment Advisors LLC lessened its stake in McKesson Co. (NYSE:MCK) by 4.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 393 shares of the company’s stock after selling 17 shares during the quarter. Angeles Investment Advisors LLC’s holdings in McKesson were worth $224,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in MCK. Cerity Partners LLC boosted its stake in McKesson by 7.6% in the 3rd quarter. Cerity Partners LLC now owns 44,224 shares of the company’s stock worth $21,867,000 after purchasing an additional 3,127 shares during the period. Penserra Capital Management LLC boosted its position in shares of McKesson by 21.7% during the third quarter. Penserra Capital Management LLC now owns 1,075 shares of the company’s stock worth $530,000 after buying an additional 192 shares during the period. Larson Financial Group LLC grew its holdings in shares of McKesson by 4.3% during the third quarter. Larson Financial Group LLC now owns 1,141 shares of the company’s stock worth $564,000 after buying an additional 47 shares in the last quarter. Centaurus Financial Inc. raised its position in McKesson by 518.4% in the 3rd quarter. Centaurus Financial Inc. now owns 2,152 shares of the company’s stock valued at $1,064,000 after buying an additional 1,804 shares during the last quarter. Finally, Summit Trail Advisors LLC lifted its stake in McKesson by 11.9% in the 3rd quarter. Summit Trail Advisors LLC now owns 1,401 shares of the company’s stock valued at $693,000 after acquiring an additional 149 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

Insiders Place Their Bets

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the firm’s stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the transaction, the chief executive officer now owns 60,664 shares in the company, valued at $36,276,465.36. This trade represents a 12.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Leann B. Smith sold 188 shares of the stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares in the company, valued at approximately $640,679.09. This trade represents a 15.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 18,689 shares of company stock worth $11,187,351 in the last 90 days. Company insiders own 0.11% of the company’s stock.

McKesson Price Performance

Shares of MCK opened at $661.56 on Tuesday. The company’s 50-day moving average is $617.68 and its 200-day moving average is $575.39. The firm has a market capitalization of $82.91 billion, a PE ratio of 30.29, a PEG ratio of 1.29 and a beta of 0.52. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $670.79.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Analysts predict that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be issued a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.43%. The ex-dividend date of this dividend is Monday, March 3rd. McKesson’s dividend payout ratio is 13.00%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on MCK. Citigroup decreased their target price on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a research report on Friday, January 10th. Mizuho began coverage on McKesson in a report on Wednesday, December 4th. They set a “neutral” rating and a $630.00 target price on the stock. Morgan Stanley increased their price target on McKesson from $612.00 to $642.00 and gave the company an “overweight” rating in a research report on Tuesday, December 17th. Bank of America dropped their price objective on McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Wells Fargo & Company raised their target price on shares of McKesson from $641.00 to $691.00 and gave the company an “equal weight” rating in a research note on Friday, March 14th. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $649.36.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.